11. Oppfølging og etterkontroll etter avsluttet kurativ behandling

ACOG (2014). Tamoxifen and Uterine Cancer (Number 601, June 2014). Washington, DC: The American College of Obstetricians and Gynecologists, Committee on Gynecologic Practice. Hentet fra https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2014/06/tamoxifen-and-uterine-cancer

Beltran-Bless, A. A., & Clemons, M. (2023). How Frequently Should Patients with Breast Cancer Have Routine Follow-Up Visits?. NEJM evidence, 2(8), EVIDtt2300062.

Browall, M., Forsberg, C., & Wengström, Y. (2017). Assessing patient outcomes and cost-effectiveness of nurse-led follow-up for women with breast cancer - have relevant and sensitive evaluation measures been used?. Journal of clinical nursing, 26(13-14), 1770-1786.

Brown, T., Cruickshank, S., & Noblet, M. (2021). Specialist breast care nurses for support of women with breast cancer. Cochrane database of systematic reviews, 2(2), CD005634.

Camps-Herrero, J., Pijnappel, R., & Balleyguier, C. (2024). MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate. European radiology, 34(10), 6264-6270.

Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019). Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of oncology, 30(8), 1194-1220.

Chan, R. J., Teleni, L., McDonald, S., Kelly, J., Mahony, J., Ernst, K., Patford, K., Townsend, J., ... Yates, P. (2020). Breast cancer nursing interventions and clinical effectiveness: a systematic review. BMJ supportive & palliative care, 10(3), 276-286.

Chu, S. C., Hsieh, C. J., Wang, T. F., Hong, M. K., & Chu, T. Y. (2020). Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan. Tzu chi medical journal, 32(2), 175-180.

Cluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D., Berenger, C., Carrieri, M. P., & Giorgi, R. (2012). Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Annals of oncology, 23(4), 882-90.

Collin, L. J., Cronin-Fenton, D. P., Ahern, T. P., Goodman, M., McCullough, L. E., Waller, L. A., Kjærsgaard, A., Damkier, P., ... Lash, T. L. (2021). Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(5), 1421-1428.

de Bock, G. H., Bonnema, J., van der Hage, J., Kievit, J., & van de Velde, C. J. (2004). Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. Journal of clinical oncology, 22(19), 4010-8.

Dragvoll, I., Bofin, A. M., Søiland, H., Taraldsen, G., & Engstrøm, M. J. (2022). Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer. BMC Cancer, 22(1), 1247.

Dumas, E., Jochum, F., Coussy, F., Hamy, A. S., Majdling, A., Houzard, S., Le Bihan-Benjamin, C., Reyal, F., ... Stensrud, M. J. (2025). Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor-Positive Early Breast Cancer: A Nationwide Cohort Study. Journal of clinical oncology, 43(16), 1863-1874.

Dunn, J. A., Donnelly, P., Elbeltagi, N., Marshall, A., Hopkins, A., Thompson, A. M., Audisio, R., Pinder, S. E., ... Evans, A. (2025). Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial. Lancet, 405(10476), 396-407.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet, 378(9793), 771-84.

Falstie-Jensen, A. M., Esen, B., Kjærsgaard, A., Lorenzen, E. L., Jensen, J. D., Reinertsen, K. V., Dekkers, O. M., Ewertz, M., & Cronin-Fenton, D. P. (2020). Incidence of hypothyroidism after treatment for breast cancer-a Danish matched cohort study. Breast cancer research, 22(1), 106.

Franzoi, M. A., Agostinetto, E., Perachino, M., Del Mastro, L., de Azambuja, E., Vaz-Luis, I., Partridge, A. H., & Lambertini, M. (2021). Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. The Lancet. Oncology, 22(7), e303-e313.

Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thurlimann, B., & Senn, H. J. (2005). Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Annals of oncology, 16(10), 1569-1583.

Hassett, M. J., Somerfield, M. R., Baker, E. R., Cardoso, F., Kansal, K. J., Kwait, D. C., Plichta, J. K., Ricker, C., ... Giordano, S. H. (2020). Management of Male Breast Cancer: ASCO Guideline. Journal of clinical oncology, 38(16), 1849-1863.

Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W. Y., Fehrenbacher, L., Gomez, S. L., ... Neugut, A. I. (2010). Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. Journal of clinical oncology, 28(27), 4120-8.

Ignatov, A., Eggemann, H., Burger, E., & Ignatov, T. (2018). Patterns of breast cancer relapse in accordance to biological subtype. Journal of Cancer Research and Clinical Oncology, 144(7), 1347-1355.

Joensuu, H., & Viikari, J. (1986). Thyroid function after postoperative radiation therapy in patients with breast cancer. Acta radiologica. Oncology, 25(3), 167-170.

Johansson, A. L. V., Trewin, C. B., Fredriksson, I., Reinertsen, K. V., Russnes, H., & Ursin, G. (2021). In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study. Breast cancer research : BCR, 23(1), 17.

Khatcheressian, J. L., Wolff, A. C., Smith, T. J., Grunfeld, E., Muss, H. B., Vogel, V. G., Halberg, F., Somerfield, M. R., & Davidson, N. E. (2006). American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. Journal of clinical oncology, 24(31), 5091-5097.

Lewin, A. A., Moy, L., Baron, P., Didwania, A. D., diFlorio-Alexander, R. M., Hayward, J. H., Le-Petross, H. T., Newell, M. S., ... Slanetz, P. J. (2019). ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women. Journal of the American College of Radiology : JACR, 16(11s), S428-s439.

Liu, Y., Malin, J. L., Diamant, A. L., Thind, A., & Maly, R. C. (2013). Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication. Breast cancer research and treatment, 137(3), 829-36.

Lu, W. L., Jansen, L., Post, W. J., Bonnema, J., Van de Velde, J. C., & De Bock, G. H. (2009). Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast cancer research and treatment, 114(3), 403-12.

Mattson, J., Peltola, M., Poikonen-Saksela, P., Hermanson, T., Their, J., Färkkilä, N., Roine, R., & Blomqvist, C. (2023). Digital solution in the follow-up of early breast cancer a randomized study. Acta oncologica (Stockholm, Sweden), 62(5), 513-521.

Montgomery, D. A., Krupa, K., & Cooke, T. G. (2007). Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. British Journal of Cancer, 97(12), 1632-41.

Moschetti, I., Cinquini, M., Lambertini, M., Levaggi, A., & Liberati, A. (2016). Follow-up strategies for women treated for early breast cancer. Cochrane database of systematic reviews, 2016(5), CD001768.

Nolan, L., Davey, M. G., Calpin, G. G., Ryan É, J., & Boland, M. R. (2024). Risk of locoregional recurrence after breast cancer surgery by molecular subtype-a systematic review and network meta-analysis. Irish journal of medical science, 193(6), 2965-2974.

Pagan, E., Ruggeri, M., Bianco, N., Bucci, E. O., Graffeo, R., Borner, M., Giordano, M., Gianni, L., ... Ribi, K. (2024). Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. Breast (Edinburgh, Scotland), 77, 103765.

Palli, D., Russo, A., Saieva, C., Ciatto, S., Rosselli Del, T. M., Distante, V., & Pacini, P. (1999). Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA, 281(17), 1586.

Pan, H., Gray, R., Braybrooke, J., Davies, C., Taylor, C., McGale, P., Peto, R., Pritchard, K. I., ... Hayes, D. F. (2017). 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. New England Journal of Medicine, 377(19), 1836-1846.

Reinertsen, K. V., Cvancarova, M., Wist, E., Bjøro, T., Dahl, A. A., Danielsen, T., & Fossa, S. D. (2009). Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. International journal of radiation oncology, biology, physics, 75(3), 764-770.

Riis, C. L., Jensen, P. T., Bechmann, T., Möller, S., Coulter, A., & Steffensen, K. D. (2020). Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer - a pilot randomized controlled trial. Acta oncologica (Stockholm, Sweden), 59(4), 444-452.

Rojas, M. P., Telaro, E., Russo, A., Moschetti, I., Coe, L., Fossati, R., Palli, D., del Roselli, T. M., & Liberati, A. (2005). Follow-up strategies for women treated for early breast cancer. Cochrane database of systematic reviews, (1), CD001768.

Ryu, K. J., Kim, M. S., Lee, J. Y., Nam, S., Jeong, H. G., Kim, T., & Park, H. (2022). Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer. JAMA network open, 5(11), e2243951.

Saltbæk, L., Bidstrup, P. E., Karlsen, R. V., Høeg, B. L., Horsboel, T. A., Belmonte, F., Andersen, E. A. W., Zoffmann, V., ... Johansen, C. (2024). Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial. Journal of clinical oncology, 42(17), 2038-2049.

Sartor, H., Hagberg, O., Hemmingsson, O., Lång, K., & Wadsten, C. (2025). Breast cancer recurrence in relation to mode of detection: implications on personalized surveillance. Breast cancer research and treatment, 209(1), 85-92.

Schmidt, J. A., Woolpert, K. M., Hjorth, C. F., Farkas, D. K., Ejlertsen, B., & Cronin-Fenton, D. (2024). Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer. Journal of clinical oncology, 42(28), 3300-3307.

Schumacher, J. R., Neuman, H. B., Yu, M., Vanness, D. J., Si, Y., Burnside, E. S., Ruddy, K. J., Partridge, A. H., ... Greenberg, C. C. (2022). Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01). Journal of the National Cancer Institute, 114(10), 1371-1379.

Solmunde, E., Falstie-Jensen, A. M., Lorenzen, E. L., Ewertz, M., Reinertsen, K. V., Dekkers, O. M., & Cronin-Fenton, D. P. (2023). Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis. Breast (Edinburgh, Scotland), 68, 216-224.

Surujballi, J., Shah, H., Hutton, B., Alzahrani, M., Beltran-Bless, A. A., Shorr, R., Larocque, G., McGee, S., ... Clemons, M. (2021). The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer. Cancer Treatment Reviews, 97, 102188.

Swinnen, J., Keupers, M., Soens, J., Lavens, M., Postema, S., & Van Ongeval, C. (2018). Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review. Insights into imaging, 9(6), 961-970.

Wassermann, J., Gelber, S. I., Rosenberg, S. M., Ruddy, K. J., Tamimi, R. M., Schapira, L., Borges, V. F., Come, S. E., ... Partridge, A. H. (2019). Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer. Cancer, 125(18), 3266-3274.

Woolpert, K. M., Schmidt, J. A., Ahern, T. P., Hjorth, C. F., Farkas, D. K., Ejlertsen, B., Collin, L. J., Lash, T. L., & Cronin-Fenton, D. P. (2024). Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients. Breast cancer research : BCR, 26(1), 59.

Yamamoto, M., Serizawa, T., Shuto, T., Akabane, A., Higuchi, Y., Kawagishi, J., Yamanaka, K., Sato, Y., ... Tsuchiya, K. (2014). Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. The Lancet. Oncology, 15(4), 387-95.